'Antifungal therapy' diaporamas de présentation

Differential Diagnosis of Oral and Maxillofacial Diseases for the Non-Dental Provider

1.15k views • 66 slides

CSS Istiocitosi

CSS Istiocitosi. Giornate AIEOP Verona 2006 . Aggiornamento studi: LCH-3. Studio in corso Arruolamento regolare su scala internazionale per i casi MS Mancata segnalazione dei casi meno gravi ! Mancata randomizzazione MS low risk Mancata registrazione MFB

870 views • 59 slides

ANTIFUNGAL THERAPY IN FEBRILE NEUTROPENIC PATIENTS REVIEW OF TREATMENT CHOICES AND STRATEGIES

ANTIFUNGAL THERAPY IN FEBRILE NEUTROPENIC PATIENTS REVIEW OF TREATMENT CHOICES AND STRATEGIES. Jean KLASTERSKY, M.D. , Ph. D. Institut Jules Bordet, Brussels, Belgium. G.S. MARTIN et al., NEJM 2003. Mc Neil M, CID 2001;13:;641-647.

892 views • 56 slides

Principles of Oral Health Management for the HIV/AIDS Patient

Principles of Oral Health Management for the HIV/AIDS Patient. A Course of Training for the Oral Health Professional.

517 views • 50 slides

Clinical failure and its management

Clinical failure and its management. David W. Denning Director, National Aspergillosis Centre University Hospital South Manchester [Wythenshawe Hospital] The University of Manchester. Problems with antifungal therapy. Drug toxicity Drug interactions and low blood levels. Drug toxicities

606 views • 48 slides

Clinical failure and its management

Clinical failure and its management. David W. Denning Director, National Aspergillosis Centre University Hospital South Manchester [Wythenshawe Hospital] The University of Manchester. Problems with antifungal therapy. Drug toxicity Drug interactions and low blood levels. Drug toxicities

623 views • 48 slides

Clinical failure and its management

Clinical failure and its management. David W. Denning Director, National Aspergillosis Centre University Hospital South Manchester [Wythenshawe Hospital] The University of Manchester. Problems with antifungal therapy. Drug toxicity Drug interactions and low blood levels. Drug toxicities

502 views • 48 slides

The Importance of Early Appropriate Therapy of Invasive Aspergillosis

The Importance of Early Appropriate Therapy of Invasive Aspergillosis. Helen Whamond Boucher, MD Division of Infectious Diseases Tufts University-New England Medical Center Boston, Massachusetts. Early Appropriate Therapy for Invasive Aspergillosis.

388 views • 38 slides

Malcolm Richardson PhD, FIBiol, FRCPath Associate Professor in Medical Mycology

Liposomal amphotericin B: 20 years of clinical experience The body of knowledge and familiarity of use. Malcolm Richardson PhD, FIBiol, FRCPath Associate Professor in Medical Mycology University of Helsinki Finland Malcolm.richardson@helsinki.fi. Echinocandins under development

470 views • 30 slides

Dr Muhammad J Motiwala MD, FACP, Al Mafraq Hospital Abu Dhabi-UAE

494 views • 30 slides

Fungal infections in hematology patients: advances in prophylaxis and treatment

ASIA-PACIFIC HEMATOLOGY CONSORTIUM. Fungal infections in hematology patients: advances in prophylaxis and treatment. Vincent CC Cheng MBBS (HK), MD (HK), PDipID (HK), MCRP (UK), FRCPath (UK), FHKCPath , FHKAM (Path) Department of Microbiology Queen Mary Hospital.

427 views • 29 slides

Key reasons underlying the demand for noninvasive and reliable fungal diagnostic tools

295 views • 28 slides

New (and newer) antifungals for invasive aspergillosis

Treatment of Invasive Aspergillosis: Polyenes, Azoles, Echinocandins? Thomas F. Patterson, MD Professor of Medicine Director, San Antonio Center for Medical Mycology The University of Texas Health Science Center at San Antonio . New (and newer) antifungals for invasive aspergillosis.

708 views • 27 slides

Initial Antifungal Therapy for Critical Ill Patients When and Which ?

Initial Antifungal Therapy for Critical Ill Patients When and Which ?. 2012-02-21. ???? ???? ??? Lin, Horng-Chyuan Division of Pulmonary Infectious & Immunological Disease Department of Thoracic Medicine Chang Gung Memorial Hospital Chang Gung University. Fungal Infections in the ICU.

724 views • 14 slides

Primary aim

Observational study to determine the rate of occurrence of invasive mould disease and treatment outcomes in at-risk patients: a European prospective invasive mould disease audit ( PIMDA). Primary aim.

105 views • 9 slides

Mortality Due to Invasive Mycoses

Mortality Due to Invasive Mycoses. United States, 1980-1997. McNeil MM, et al. Clin Infect Dis 2001;33:641-7. Invasive Aspergillosis Mortality Review of Literature after 1995. Review of 1941 Patients from 50 Studies. Lin S-J et al, Clin Infect Dis 2001; 32:358-66.

179 views • 8 slides